During the past decade, Cary Skin Care conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cary Skin Care" are "Crow's Feet" (2 trials) and "Lateral Canthal Lines" (2 trials). Many other conditions were trialed in "Cary Skin Care" in a lesser frequency.

Most popular intervention types in "Cary Skin Care" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "ANT-1207" (1 trials), "Botulinum Toxin Type A" (1 trials), "Botulinum Toxin, Type A" (1 trials), "Vehicle" (1 trials) and "botulinum toxin, Type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cary Skin Care" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cary Skin Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cary Skin Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cary Skin Care, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".